Committed to Improving the Lives of Patients Worldwide
Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of Hematologic cancer, cancer and other severe, immune, inflammatory conditions.